Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-72,302
Closed -$2.89M 5127
2026
Q1
$2.89M Buy
72,302
+24,015
+50% +$1.14M 0.01% 1348
2025
Q4
$2.17M Buy
48,287
+24,802
+106% +$1.15M 0.01% 1250
2025
Q3
$1.05M Buy
23,485
+661
+3% +$31.6K ﹤0.01% 1496
2025
Q2
$1.1M Buy
22,824
+12,845
+129% +$559K ﹤0.01% 1220
2025
Q1
$400K Buy
+9,979
New +$420K ﹤0.01% 1603
2024
Q4
Sell
-15,453
Closed -$724K 3070
2024
Q3
$724K Sell
15,453
-8,108
-34% -$370K ﹤0.01% 1411
2024
Q2
$995K Buy
+23,561
New +$1.03M 0.01% 1018
2022
Q1
Sell
-5,800
Closed -$341K 3715
2021
Q4
$341K Buy
+5,800
New +$333K ﹤0.01% 2181
2021
Q3
Sell
-29,553
Closed -$1.52M 3670
2021
Q2
$1.52M Buy
+29,553
New +$1.53M 0.01% 771
2020
Q3
Sell
-10,561
Closed -$479K 2262
2020
Q2
$479K Buy
+10,561
New +$473K 0.01% 793
2020
Q1
Sell
-7,281
Closed -$260K 1234
2019
Q4
$260K Buy
+7,281
New +$271K 0.01% 815

Other funds holding QGEN

HRT Financial's QGEN Position: Q2 2026 in Review

HRT Financial sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 72,302 shares — an estimated $2.89M sold.

HRT Financial first reported a position in QGEN in Q4 2019 and held it in 11 quarters. The position peaked at $2.89M in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • HRT Financial reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 72,302 Qiagen shares in Q2 2026, an estimated $2.89M.
  • HRT Financial first reported a position in Qiagen in Q4 2019 and held it in 11 quarters.
  • HRT Financial's Qiagen position peaked at $2.89M in Q1 2026.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.